971 related articles for article (PubMed ID: 18077562)
1. The brain as a target for inflammatory processes and neuroprotective strategies.
Skaper SD
Ann N Y Acad Sci; 2007 Dec; 1122():23-34. PubMed ID: 18077562
[TBL] [Abstract][Full Text] [Related]
2. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotection from complement-mediated inflammatory damage.
Kulkarni AP; Kellaway LA; Lahiri DK; Kotwal GJ
Ann N Y Acad Sci; 2004 Dec; 1035():147-64. PubMed ID: 15681806
[TBL] [Abstract][Full Text] [Related]
4. Chronic glial activation, neurodegeneration, and APP immunoreactive deposits following acute administration of double-stranded RNA.
Melton LM; Keith AB; Davis S; Oakley AE; Edwardson JA; Morris CM
Glia; 2003 Oct; 44(1):1-12. PubMed ID: 12951652
[TBL] [Abstract][Full Text] [Related]
5. MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target.
Kaminska B; Gozdz A; Zawadzka M; Ellert-Miklaszewska A; Lipko M
Anat Rec (Hoboken); 2009 Dec; 292(12):1902-13. PubMed ID: 19943344
[TBL] [Abstract][Full Text] [Related]
6. The endocannabinoid system in targeting inflammatory neurodegenerative diseases.
Centonze D; Finazzi-Agrò A; Bernardi G; Maccarrone M
Trends Pharmacol Sci; 2007 Apr; 28(4):180-7. PubMed ID: 17350694
[TBL] [Abstract][Full Text] [Related]
7. PPARgamma as a therapeutic target in central nervous system diseases.
Sundararajan S; Jiang Q; Heneka M; Landreth G
Neurochem Int; 2006 Jul; 49(2):136-44. PubMed ID: 16766086
[TBL] [Abstract][Full Text] [Related]
8. Inflammasome signaling at the heart of central nervous system pathology.
Chakraborty S; Kaushik DK; Gupta M; Basu A
J Neurosci Res; 2010 Jun; 88(8):1615-31. PubMed ID: 20127816
[TBL] [Abstract][Full Text] [Related]
9. Interleukins, inflammation, and mechanisms of Alzheimer's disease.
Weisman D; Hakimian E; Ho GJ
Vitam Horm; 2006; 74():505-30. PubMed ID: 17027528
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and the pathogenesis of neurodegenerative disorders.
Reynolds A; Laurie C; Mosley RL; Gendelman HE
Int Rev Neurobiol; 2007; 82():297-325. PubMed ID: 17678968
[TBL] [Abstract][Full Text] [Related]
11. P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases.
Takenouchi T; Sekiyama K; Sekigawa A; Fujita M; Waragai M; Sugama S; Iwamaru Y; Kitani H; Hashimoto M
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):91-6. PubMed ID: 20143170
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive intestinal peptide prevents activated microglia-induced neurodegeneration under inflammatory conditions: potential therapeutic role in brain trauma.
Delgado M; Ganea D
FASEB J; 2003 Oct; 17(13):1922-4. PubMed ID: 12923064
[TBL] [Abstract][Full Text] [Related]
13. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A
Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964
[TBL] [Abstract][Full Text] [Related]
14. Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions.
McGeer PL; McGeer EG
Alzheimer Dis Assoc Disord; 1998; 12 Suppl 2():S1-6. PubMed ID: 9769023
[TBL] [Abstract][Full Text] [Related]
15. Role of nerve growth factor and other trophic factors in brain inflammation.
Villoslada P; Genain CP
Prog Brain Res; 2004; 146():403-14. PubMed ID: 14699976
[TBL] [Abstract][Full Text] [Related]
16. Experimental brain inflammation and neurodegeneration as model of Alzheimer's disease: protective effects of selective COX-2 inhibitors.
Giovannini MG; Scali C; Prosperi C; Bellucci A; Pepeu G; Casamenti F
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):31-40. PubMed ID: 14552702
[TBL] [Abstract][Full Text] [Related]
17. Inflammation and Alzheimer's disease.
Lee YJ; Han SB; Nam SY; Oh KW; Hong JT
Arch Pharm Res; 2010 Oct; 33(10):1539-56. PubMed ID: 21052932
[TBL] [Abstract][Full Text] [Related]
18. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.
Walker DG; Lue LF
J Neurosci Res; 2005 Aug; 81(3):412-25. PubMed ID: 15957156
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effects of m-chlorophenylpiperazine in brain glia cells.
Hwang J; Zheng LT; Ock J; Lee MG; Suk K
Int Immunopharmacol; 2008 Dec; 8(12):1686-94. PubMed ID: 18771755
[TBL] [Abstract][Full Text] [Related]
20. Glial reactions in Parkinson's disease.
McGeer PL; McGeer EG
Mov Disord; 2008 Mar; 23(4):474-83. PubMed ID: 18044695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
